Hillsdale Investment Management Inc.

Position in VTRS — Viatris Inc

CIK 1368465 Toronto, A6

Back to VTRS Full portfolio

Position in VTRS

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$1,456,378

+$337,123 QoQ

Shares Held

107,800

+19.9% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Hillsdale Investment Management Inc. holds $35,500,367 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	743,679	$9,243,929
2	PCRX	Pacira BioSciences, Inc.	331,300	$7,487,380
3	COLL	Collegium Pharmaceutical, Inc	184,600	$6,104,722
4	BCRX	Biocryst Pharmaceuticals Inc	639,100	$6,084,232
5	IRWD	Ironwood Pharmaceuticals Inc	1,236,628	$4,340,564
6	VTRS	Viatris Inc This page	107,800	$1,456,378
7	PAHC	Phibro Animal Health Corp	7,500	$414,825
8	ANIK	Anika Therapeutics, Inc.	25,400	$368,300

All Filings in VTRS

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,456,378	107,800	+19.9%	Shares	Sole	2026-05-04
2025-12-31	$1,119,255	89,900	+34.8%	Shares	Sole	2026-02-10
2025-06-30	$595,631	66,700	-3.2%	Shares	Sole	2025-08-12
2025-03-31	$600,119	68,900	+47.7%	Shares	Sole	2025-05-09
2023-06-30	$465,567	46,650	+16.2%	Shares	Sole	2023-08-11
2023-03-31	$386,243	40,150	-19.1%	Shares	Sole	2023-05-10
2022-12-31	$552,048	49,600	-8.0%	Shares	Sole	2023-02-13
2022-09-30	$459,228	53,900	0.0%	Shares	Sole	2022-11-10
2022-06-30	$564,333	53,900	+48900.0%	Shares	Sole	2022-08-12
2020-12-31	$2,061	110	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.